Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 4Breast 3Other hematologic neoplasm 2Dermatologic 2Plasma cell 1Head & Neck 1Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 2Leukemia 1

Interventions

Cytarabine 184Cyclophosphamide 176fludarabine 146Azacitidine 121venetoclax 115fludarabine phosphate 104Rituximab 80Decitabine 74Filgrastim 58Specimen Handling 55Etoposide 55Lenalidomide 47Biopsy 45Dexamethasone 41Methotrexate 40Bortezomib 40Mitoxantrone 39Granulocyte Colony-Stimulating Factor 39Daunorubicin 39Vincristine 37Melphalan 36ibrutinib 35Tacrolimus 35Dasatinib 34Whole-Body Irradiation 32Clofarabine 32Peripheral Blood Stem Cell Transplantation 31Mycophenolic Acid 31Injections 31Idarubicin 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Bexarotene × Other hematologic neoplasm × Clear all
NCT00316030 2016-06-08

Study of Bexarotene in Patients With Acute Myeloid Leukemia

Abramson Cancer Center at Penn Medicine

Phase 1 Completed
54 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

NCT01001143 2014-07-29

AML

Washington University School of Medicine

Phase 1 Completed
19 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡